Instituto de Saude Publica da Universidade do Porto
14
4
4
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Nutrition-based Interventions to Prevent Cognitive Decline
Role: lead
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Role: collaborator
Intervention Project to Increase Adherence to Colorectal Cancer Screening in Barcelos/Esposende
Role: collaborator
Reengineering Cervical Cancer Screening for the 21st Century: Joint Action for a Novel Up-to-date and Sustainable Screening Program
Role: lead
Improving Learning and Memory in Portuguese Patients With Multiple Sclerosis
Role: collaborator
Improving the Referral of Patients With Suspected Cognitive Impairment and Early Dementia
Role: collaborator
Tuberculosis Screening in Paraguayan Prisons
Role: collaborator
Multiple Interventions to Accelerate the Return to the Pre-event Level of Functioning After a TIA and Minor Stroke
Role: lead
MIND-Matosinhos: Multiple Interventions to Prevent Cognitive Decline
Role: lead
Impact of COVID-19 Pandemic in Perinatal Mental Health (RISEUP-PPD-COVID-19)
Role: collaborator
COVID-19: A Scope Research on Epidemiology and Clinical Course
Role: lead
Experimental Study to Reduce Low Birthweight
Role: lead
Improving MAternal Newborn carE In the in the WHO European Region During COVID-19 Pandemic
Role: collaborator
A Mobile App to Improve Participation in Following-up Cohorts
Role: lead
All 14 trials loaded